Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001264124-12-000058)

Filing Details

Accession Number:: 0001264124-12-000058
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-02-24 17:02:26
Reporting Period:: 2012-02-22

Filing Date:: 2012-02-24
Accepted Time:: 2012-02-24 17:02:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
881464	Amylin Pharmaceuticals Inc	AMLN	Pharmaceutical Preparations (2834)	330266089

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1236394	G Orville Kolterman	9360 Towne Centre Dr San Diego CA 92121	Svp, Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-02-22	15,000	$0.00	180,820	No	4	A	Direct
Common Stock	Disposition	2012-02-23	5,638	$17.03	175,182	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	12,767	Indirect	Indirect-401k
Common Stock	6,445	Indirect	by ESOP

Footnotes

Represents shares acquired upon vesting of performance-based restricted stock units.
Sale of common shares to satisfy reporting person's income tax withholding obligations due upon vesting of performance-based restricted stock units.
These shares fully vested four years from the date of the reporting person's participation in the ESOP in four equal annual installments and are generally distributed upon termination of employment.